Natera, Inc. (NASDAQ:NTRA) has been given an average rating of “Hold” by the eight research firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $16.20.

Several analysts recently weighed in on the company. Morgan Stanley restated an “overweight” rating and issued a $16.00 price objective (up from $13.00) on shares of Natera in a report on Friday, October 6th. Zacks Investment Research upgraded Natera from a “sell” rating to a “buy” rating and set a $15.00 price objective for the company in a report on Wednesday, October 11th. Cowen and Company restated a “buy” rating and issued a $14.00 price objective on shares of Natera in a report on Friday, September 1st. BidaskClub upgraded shares of Natera from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Finally, ValuEngine upgraded shares of Natera from a “strong sell” rating to a “sell” rating in a report on Thursday, August 10th.

TRADEMARK VIOLATION WARNING: “Natera, Inc. (NTRA) Given Average Rating of “Hold” by Brokerages” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/10/22/natera-inc-ntra-given-average-rating-of-hold-by-brokerages.html.

In other Natera news, insider Jonathan Sheena sold 120,000 shares of the business’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $12.54, for a total value of $1,504,800.00. Following the completion of the transaction, the insider now directly owns 533,208 shares in the company, valued at $6,686,428.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 12.57% of the company’s stock.

A number of institutional investors have recently made changes to their positions in NTRA. Macquarie Group Ltd. raised its holdings in Natera by 112.3% in the second quarter. Macquarie Group Ltd. now owns 1,061,880 shares of the medical research company’s stock worth $11,532,000 after purchasing an additional 561,659 shares in the last quarter. Broadview Advisors LLC bought a new position in Natera in the second quarter worth about $5,490,000. Vanguard Group Inc. raised its holdings in Natera by 12.6% in the second quarter. Vanguard Group Inc. now owns 2,261,052 shares of the medical research company’s stock worth $24,555,000 after purchasing an additional 253,344 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Natera by 28.2% in the first quarter. Renaissance Technologies LLC now owns 411,400 shares of the medical research company’s stock worth $3,649,000 after purchasing an additional 90,600 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS raised its holdings in Natera by 22.2% in the second quarter. Kornitzer Capital Management Inc. KS now owns 436,290 shares of the medical research company’s stock worth $4,738,000 after purchasing an additional 79,325 shares in the last quarter. Institutional investors and hedge funds own 59.79% of the company’s stock.

Natera (NTRA) traded up 1.38% during mid-day trading on Friday, hitting $13.20. 70,738 shares of the stock were exchanged. The stock’s market cap is $702.54 million. The stock has a 50 day moving average of $13.07 and a 200-day moving average of $13.07. Natera has a 52-week low of $7.88 and a 52-week high of $14.76.

Natera (NASDAQ:NTRA) last released its quarterly earnings data on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share for the quarter, meeting the consensus estimate of ($0.52). The firm had revenue of $53.60 million during the quarter, compared to the consensus estimate of $50.57 million. Natera had a negative return on equity of 137.46% and a negative net margin of 62.64%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted ($0.46) earnings per share. Equities analysts predict that Natera will post ($2.03) EPS for the current fiscal year.

About Natera

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.